Prehospital transdermal glyceryl trinitrate for ultra-acute ischaemic stroke: data from the RIGHT-2 randomised sham-controlled ambulance trial

Appleton, Jason Philip; Woodhouse, Lisa J.; Anderson, Craig S.; Ankolekar, Sandeep; Cala, Lesley; Dixon, Mark; England, Timothy J.; Krishnan, Kailash; Mair, Grant; Muir, Keith W.; Potter, John; Price, Christopher I.; Randall, Marc; Robinson, Thompson G.; Roffe, Christine; Sandset, Else C.; Saver, Jeffrey L.; Shone, Angela; Siriwardena, Aloysius Niroshan; Wardlaw, Joanna M.; Sprigg, Nikola; Bath, Philip M.

doi:10.1136/svn-2022-001634

All Outputs (2)

Surgery for Malignant Acute Ischemic Stroke: A Narrative Review of the Knowns and Unknowns (2023)
Journal Article

Malignant acute ischemic stroke (AIS) is characterized by acute neurological deterioration caused by progressive space-occupying brain edema, often occurring in the first hours to days after symptom onset. Without any treatment, the result is often f... Read More about Surgery for Malignant Acute Ischemic Stroke: A Narrative Review of the Knowns and Unknowns.

Prehospital transdermal glyceryl trinitrate for ultra-acute ischaemic stroke: data from the RIGHT-2 randomised sham-controlled ambulance trial (2023)
Journal Article

Background The effect of transdermal glyceryl trinitrate (GTN, a nitrovasodilator) on clinical outcome when administered before hospital admission in suspected stroke patients is unclear. Here, we assess the safety and efficacy of GTN in the prespeci... Read More about Prehospital transdermal glyceryl trinitrate for ultra-acute ischaemic stroke: data from the RIGHT-2 randomised sham-controlled ambulance trial.